Table 2.
Age | Lymphocyte telomere lengtha | Granulocyte telomere length | CMV IgG Antibodyb | WBCc(UCLA) | #Lymph (UCLA) | % CD3 (UCLA) | # CD3 (UCLA) | % CD8 (UCLA) | # CD8 (UCLA) | % CD8+ CD28− (UCLA) | # CD8+ CD28− (UCLA) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 62.5 | 5.73 kb | 6.71 | 1.83 | 5690 | 1850 | 70.1 | 1320 | 22.8 | 435 | 34.7 | 175 |
SD | 12.5 | 1.05 kb | 0.88 | 1.77 | 1520 | 565 | 8.57 | 479 | 9.14 | 250 | 19.9 | 180 |
n | 114 | 114 | 114 | 88 | 113 | 113 | 113 | 113 | 113 | 113 | 113 | 113 |
md | NA | −55 bp | −34 bp | 0.024 | 22 | −6.6 | −0.14 | −6.4 | −0.08 | −3.0 | 0.37 | 1.6 |
R squared | NA | 0.42 | 0.24 | 0.03 | 0.032 | 0.021 | 0.044 | 0.029 | 0.012 | 0.023 | 0.055 | 0.190 |
p value | NA | 4.8E-15 | 3.1E-8 | 0.11 | 0.057 | 0.12 | 0.026 | 0.073 | 0.24 | 0.11 | 0.012 | 0.25 |
# CD28+ (calc)e | % CD28+(calc) | # CD95− (UCLA) | % CD95− (UCLA) | # Lymphocytes | % Lymphocytes | # NK | % NK | % CD19 | # CD19 | % CD3 | # CD3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 260 | 65 | 63 | 18 | 1500 | 28 | 221 | 15.0 | 11.7 | 186 | 71.7 | 1150 |
SD | 132 | 20 | 53 | 12 | 524 | 8.70 | 100 | 7.2 | 5.04 | 100 | 8.16 | 414 |
n | 113 | 113 | 57 | 57 | 54 | 103 | 103 | 103 | 103 | 103 | 103 | 103 |
m | −4.6 | −0.37 | −2.7 | −0.51 | −2.5 | −0.21 | 2.2 | 0.21 | −0.13 | −2.6 | −0.091 | −3.8 |
R squared | 0.19 | 0.055 | 0.47 | 0.44 | 0.004 | 0.09 | 0.07 | 0.13 | 0.04 | 0.1 | 0.014 | 0.00 |
p value | 1.4E-06 | 0.012 | 6.7E-9 | 6.4E-6 | 0.72 | 0.002 | 0.006 | 0.00015 | 0.00067 | 0.0011 | 0.17 | 0.25 |
CD4/CD8 ratio | % CD4+ | % CD8+ | # CD8+ | # WBC | # Neutrophils | % Neutrophils | Glucose | Serum insulin | DHEA sulfate | Testosterone (free) | Testosterone (total) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 2.8 | 49 | 22 | 370 | 5700 | 3600 | 61 | 97 | 7.1 | 148 | 33 | 400 |
SD | 2.7 | 8.9 | 8.3 | 200 | 1600 | 1300 | 9.3 | 15 | 7.0 | 131 | 42 | 340 |
n | 103 | 103 | 103 | 103 | 106 | 102 | 103 | 107 | 107 | 106 | 106 | 106 |
m | 0.064 | 0.045 | -0.10 | -2.1 | 230 | 31 | 0.17 | 0.33 | 0.025 | −2.6 | 0.23 | 1.1 |
R squared | 0.007 | 0.004 | 0.023 | 0.017 | 0.08 | 0.05 | 0.08 | 0.002 | 0.06 | 0.005 | 0.002 | |
p value | 0.0024 | 0.53 | 0.13 | 0.19 | 0.051 | 0.039 | 0.020 | 0.00460 | 0.64 | 0.011 | 0.47 | 0.31 |
Cholesterol (total) | Cholesterol (LDL) | SBP | DBP | Homocysteine | Serum folate | Vitamin D 25-OH total | Vitamin B12 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 190 | 110 | 130 | 77 | 11 | 17 | 40 | 790 | ||||
SD | 38 | 34 | 19 | 10 | 3.6 | 5.8 | 16 | 410 | ||||
n | 105 | 104 | 97 | 97 | 107 | 103 | 107 | 105 | ||||
m | −0.29 | −0.37 | 0.51 | −0.018 | 0.066 | −0.12 | 0.11 | 6.1 | ||||
R squared | 0.01 | 0.02 | 0.108 | 0.000 | 0.05 | 0.02 | 0.007 | 0.036 | ||||
p value | 0.32 | 0.16 | 0.0010 | 0.83 | 0.016 | 0.0086 | 0.38 | 0.053 |
Lymphocyte and granulocyte telomere lengths are from FlowFISH analyses.
For some subjects, CMV antibody titers were first taken at a postbaseline time point.
Replicate blood samples were collected and sent to UCLA Clinical Labs for analyses which focused on assessment of senescent CD28−/CD8+ T cells, and to Quest Diagnostics for routine blood counts. Discrepancies in numbers for the same lab analysis likely reflect variations between laboratory techniques. Table entries represent data from Quest except where UCLA is indicated.
Slope of the linear regression line of variable indicated versus age of donor.
Number and percent CD8+CD28+ cells were derived from the measured number of CD8+CD28− and total CD8+ cells.
CMV, Cytomegalovirus; IgG, immunoglobulin G; SD, standard deviation; NK, natural killer; WBC, white blood cells; DHEA, 5-dehydroepiandrosterone; LDL, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; FlowFISH, Flow fluorescence in situ hybridization.